Silo Pharma’s Sponsored Research Agreement with Columbia Could Yield a New Alzheimer’s Disease Treatment
November 3, 2021
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
December 20, 2018
Pascal Biosciences Announces Optimization of Cannabinoid-Derived Drug Candidates to Kill Glioblastoma Cells
November 5, 2018
Bloomberg Interviews FSD Pharma for Cannabis Shortage Feature
October 30, 2018